P450 Monooxygenases and Renal Vascular Function
P450 单加氧酶和肾血管功能
基本信息
- 批准号:7758889
- 负责人:
- 金额:$ 23.72万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-05 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAfrican AmericanAgonistAlbuminuriaAlkane 1-monooxygenaseAllelesAnabolismAnimal ModelAnimalsAntihypertensive AgentsArachidonic AcidsAreaAttenuatedBasic ScienceBiochemicalBiochemistryBiologicalBiologyBiometryBlood PressureBlood VesselsBody FluidsBostonCYP2C9 geneCYP4A11 geneCardiovascular DiseasesCardiovascular PhysiologyCardiovascular systemCaucasiansCaucasoid RaceCellsCellular biologyCerebrumChronicClinicalClinical ManagementClinical ResearchComplications of Diabetes MellitusCytochrome P450DNA SequenceDNA Sequencing FacilityDataDevelopmentDiabetes MellitusDiabetic NephropathyDiagnosticDiseaseDistalDiureticsEarly DiagnosisEconomicsEicosanoidsElectrophysiology (science)ElementsEnzymatic BiochemistryEnzymesEpidemiologistEvaluationFenofibrateFunctional disorderFundingFutureGene StructureGene TargetingGenerationsGenesGeneticGenetic ResearchGenetic TechniquesGenetic VariationGenomeGenomicsGenotypeGoalsHealthHome environmentHomologous GeneHumanHuman GeneticsHydroxyeicosatetraenoic AcidsHydroxylationHypertensionIndividualInstitutesInstitutionInsulinInterest GroupInterventionKidneyKidney DiseasesKnockout MiceKnowledgeLaboratoriesLeadLeadershipLigandsMediatingMediator of activation proteinMedicalMetabolicMetabolic syndromeMicroarray Shared ResourceMixed Function OxygenasesModelingMolecularMolecular GeneticsMorbidity - disease rateMusNatureNephronsNon-Insulin-Dependent Diabetes MellitusNuclear ReceptorsOrganOutcomePathway interactionsPharmacogeneticsPharmacology and ToxicologyPhenotypePhysiciansPhysiologicalPhysiologyPlasmaPlayPopulationPositioning AttributePrevalencePropertyProtein IsoformsProteinsPublic Health SchoolsPublicationsPublishingRattusRegulationRenal HypertensionRenal functionResearchResearch PersonnelResourcesRoleRunningScientistSiteSodiumSolidSystemTalentsTechnologyTestingTherapeuticTranslatingTranslational ResearchTubular formationUniversitiesUp-RegulationUrineVariantWisconsinWorkbaseblood pressure regulationclinical Diagnosisclinically relevantcohortcytochrome P-450 CYP2C subfamilydb/db mousediabeticexperiencefamilial hypertensiongenetic associationhemodynamicshuman diseasein vivoinsightinsulin sensitivityinsulin sensitizing drugsinterdisciplinary approachinterestkidney vascular structureloss of functionmedical schoolsmeetingsmembermortalitymouse modelmultidisciplinarynext generationnormotensivenovel strategiespreventprofessorprotective effectreceptorrenal tubular transportresearch studyresponsesalt intaketooltool developmentvasoconstriction
项目摘要
The kidney plays a key role in the control of body fluid volume and composition, and tubular and/or
hemodynamic dysfunction are common features of diseases such as hypertension and diabetes. The renal
P450 arachidonic acid (AA) monooxygenase biosynthesizes hydroxy- and epoxy-AA derivatives that are
known to modulate tubular transport and vascular reactivity. Animal models of P450 gene dysfunction
confirmed the physiological importance of these enzymes, characterized their pathophysiological roles, and
provided insights into the mechanism of action of their metabolites. Studies of the pathophysiological roles of
human P450s identified associations between P450 gene variants with hypertension, the progression of
renal disease, and with components of metabolic syndrome. This application proposes to build upon these
studies and to address: a) mechanisms by which the P450-eicosanoids regulate renal tubular transport and
vascular reactivity, b) the role of P450s in human hypertension and renal complications of diabetes, and c)
the molecular basis of these pathophysiological roles. To achieve these goals, we developed a multidisciplinary
approach for studies of P450-isoform specific phenotypes at the cellular, organ and whole animal
levels, the analysis of associations between alterations in human P450 gene structure/expression and
disease, and for clinical studies of their metabolic and functional consequences. Cyp2c and Cyp4a knockout
mice will be used to study gene-dependent changes in: a) renal EET and/or 20-HETE synthase expression,
b) tubular transport and/or vascular reactivity, and c) systemic blood pressure and the progression of renal
disease. Associations between CYP2C8/2C9 or CYP4A11 genotypes with blood pressure, insulin sensitivity,
and urine and plasma EET and 20-HETE levels will be explored to define pathophysiological correlations
between variant alleles, AA epoxidation/hydroxylation, and individual responses to changes in dietary salt
intake, the administration of diuretics, or peroxisomal proliferator activated receptor (alpha) ligands. Our
long term goals are to provide a molecular understanding of role(s) of P450 eicosanoids in renal
physiological, their mechanism and site of action, and relevance to human disease. These are needed for
the development of meaningful approaches for: a) the unequivocal definition of human pathophysiological
significance, and b) future pharmacological targeting, and clinical diagnosis and intervention.
肾脏在控制体液体积和成分以及管状和/或
血液动力学功能障碍是高血压和糖尿病等疾病的常见特征。肾
P450花生四烯酸(AA)单加氧酶的生物合成羟基和环氧-AA衍生物是
已知可以调节管状转运和血管反应性。 P450基因功能障碍的动物模型
确认了这些酶的生理重要性,表征了它们的病理生理作用,并
提供了有关其代谢产物作用机理的见解。研究的病理生理作用
人类P450鉴定了P450基因变异与高血压的关联,
肾脏疾病,以及代谢综合征的成分。本申请建议以这些为基础
研究和解决:a)P450- eicosanoids调节肾小管运输和
血管反应性,b)P450在糖尿病的人类高血压和肾脏并发症中的作用,C)
这些病理生理作用的分子基础。为了实现这些目标,我们开发了一个多学科
在细胞,器官和整个动物的P450-异型特异性表型的研究方法
水平,对人P450基因结构/表达的改变与
疾病,以及有关其代谢和功能后果的临床研究。 CYP2C和CYP4A淘汰赛
小鼠将用于研究基因依赖性的变化:a)肾脏EET和/或20-HETE合酶表达,
b)管状转运和/或血管反应性,c)全身血压和肾脏的进展
疾病。 CYP2C8/2C9或CYP4A11基因型与血压,胰岛素敏感性,
将探索尿液和血浆EET以及20-HETE水平以定义病理生理相关性
在变异等位基因,AA环氧化/羟基化以及对饮食盐变化的各个反应之间
摄入量,利尿剂或过氧化物酶体增生剂活化受体(alpha)配体。我们的
长期目标是提供对肾脏中P450 eicosanoids作用的分子理解
生理学,其机制和作用部位以及与人类疾病相关的。这些是需要的
有意义的方法的发展:a)人类病理生理学的明确定义
意义和b)未来的药理学靶向,以及临床诊断和干预。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John D Imig其他文献
John D Imig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John D Imig', 18)}}的其他基金
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation
内皮环氧合酶、肾脏损伤和血压调节
- 批准号:
10415003 - 财政年份:2021
- 资助金额:
$ 23.72万 - 项目类别:
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation
内皮环氧合酶、肾脏损伤和血压调节
- 批准号:
10625377 - 财政年份:2021
- 资助金额:
$ 23.72万 - 项目类别:
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation
内皮环氧合酶、肾脏损伤和血压调节
- 批准号:
10763638 - 财政年份:2021
- 资助金额:
$ 23.72万 - 项目类别:
Endothelial Epoxygenase, Kidney Injury, and Blood Pressure Regulation
内皮环氧合酶、肾脏损伤和血压调节
- 批准号:
10317475 - 财政年份:2021
- 资助金额:
$ 23.72万 - 项目类别:
Renal Endothelial Dysfunction in Salt-Sensitive Hypertension
盐敏感性高血压中的肾内皮功能障碍
- 批准号:
7433776 - 财政年份:2007
- 资助金额:
$ 23.72万 - 项目类别:
Renal Endothelial Dysfunction in Na-Sensitive Hypertensi
钠敏感性高血压的肾内皮功能障碍
- 批准号:
7228244 - 财政年份:2006
- 资助金额:
$ 23.72万 - 项目类别:
Novel epoxide hydrolase inhibitor for stroke prevention
用于预防中风的新型环氧化物水解酶抑制剂
- 批准号:
6990653 - 财政年份:2005
- 资助金额:
$ 23.72万 - 项目类别:
相似海外基金
Mechano signals regulating tendon and ligament homeostasis
机械信号调节肌腱和韧带稳态
- 批准号:
10522344 - 财政年份:2022
- 资助金额:
$ 23.72万 - 项目类别:
The Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)
用于药物使用障碍远程管理的增强型数字化学感应嗅觉训练的开发和评估(编辑)
- 批准号:
10469912 - 财政年份:2022
- 资助金额:
$ 23.72万 - 项目类别:
Mechano signals regulating tendon and ligament homeostasis
机械信号调节肌腱和韧带稳态
- 批准号:
10707502 - 财政年份:2022
- 资助金额:
$ 23.72万 - 项目类别:
Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer
改造天然大肠杆菌来检测、报告和治疗结直肠癌
- 批准号:
10330342 - 财政年份:2021
- 资助金额:
$ 23.72万 - 项目类别: